Parkside Financial Bank & Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.06K | Sell |
156
-17
| -10% | -$416 | ﹤0.01% | 1977 |
|
|
2025
Q4 | $4.63K | Hold |
173
| – | – | ﹤0.01% | 1824 |
|
|
2025
Q3 | $4.61K | Buy |
173
+37
| +27% | +$955 | ﹤0.01% | 1760 |
|
|
2025
Q2 | $3.12K | Sell |
136
-870
| -86% | -$21.6K | ﹤0.01% | 1856 |
|
|
2025
Q1 | $29.2K | Buy |
1,006
+27
| +3% | +$862 | ﹤0.01% | 1008 |
|
|
2024
Q4 | $36.4K | Buy |
979
+871
| +806% | +$39.8K | ﹤0.01% | 906 |
|
|
2024
Q3 | $5.24K | Hold |
108
| – | – | ﹤0.01% | 1421 |
|
|
2024
Q2 | $4.32K | Hold |
108
| – | – | ﹤0.01% | 1399 |
|
|
2024
Q1 | $4.74K | Hold |
108
| – | – | ﹤0.01% | 1345 |
|
|
2023
Q4 | $6.68K | Sell |
108
-165
| -60% | -$8.67K | ﹤0.01% | 1237 |
|
|
2023
Q3 | $12.6K | Hold |
273
| – | – | ﹤0.01% | 1042 |
|
|
2023
Q2 | $15.7K | Buy |
273
+61
| +29% | +$2.7K | ﹤0.01% | 976 |
|
|
2023
Q1 | $7.95K | Buy |
212
+23
| +12% | +$754 | ﹤0.01% | 1180 |
|
|
2022
Q4 | $5.29K | Buy |
189
+72
| +62% | +$2.09K | ﹤0.01% | 1296 |
|
|
2022
Q3 | $3K | Hold |
117
| – | – | ﹤0.01% | 1369 |
|
|
2022
Q2 | $4K | Hold |
117
| – | – | ﹤0.01% | 1290 |
|
|
2022
Q1 | $4K | Hold |
117
| – | – | ﹤0.01% | 1340 |
|
|
2021
Q4 | $3K | Buy |
+117
| New | +$2.39K | ﹤0.01% | 1458 |
|
|
2021
Q3 | – | Sell |
-8
| Closed | – | – | 1747 |
|
|
2021
Q2 | $0 | Buy |
+8
| New | +$151 | ﹤0.01% | 1705 |
|
|
2021
Q1 | – | Sell |
-54
| Closed | -$1K | – | 1670 |
|
|
2020
Q4 | $1K | Buy |
54
+19
| +54% | +$370 | ﹤0.01% | 1494 |
|
|
2020
Q3 | $1K | Buy |
35
+13
| +59% | +$262 | ﹤0.01% | 1268 |
|
|
2020
Q2 | $0 | Sell |
22
-2
| -8% | -$37 | ﹤0.01% | 1471 |
|
|
2020
Q1 | $0 | Buy |
+24
| New | +$418 | ﹤0.01% | 1415 |
|
|
2019
Q4 | – | Sell |
-39
| Closed | -$1K | – | 1578 |
|
|
2019
Q3 | $1K | Buy |
39
+17
| +77% | +$354 | ﹤0.01% | 1279 |
|
|
2019
Q2 | $0 | Sell |
22
-8
| -27% | -$167 | ﹤0.01% | 1571 |
|
|
2019
Q1 | $1K | Sell |
30
-10
| -25% | -$224 | ﹤0.01% | 1269 |
|
|
2018
Q4 | $1K | Hold |
40
| – | – | ﹤0.01% | 1146 |
|
|
2018
Q3 | $1K | Buy |
40
+11
| +38% | +$196 | ﹤0.01% | 1194 |
|
|
2018
Q2 | $0 | Sell |
29
-29
| -50% | -$507 | ﹤0.01% | 1524 |
|
|
2018
Q1 | $1K | Buy |
58
+29
| +100% | +$545 | ﹤0.01% | 1105 |
|
|
2017
Q4 | $1K | Hold |
29
| – | – | ﹤0.01% | 1064 |
|
|
2017
Q3 | $1K | Hold |
29
| – | – | ﹤0.01% | 1060 |
|
|
2017
Q2 | $1K | Hold |
29
| – | – | ﹤0.01% | 1062 |
|
|
2017
Q1 | $0 | Buy |
29
+6
| +26% | +$94 | ﹤0.01% | 1349 |
|
|
2016
Q4 | $0 | Buy |
+23
| New | +$447 | ﹤0.01% | 1358 |
|
Other funds holding AMPH
VCM
BTW
Parkside Financial Bank & Trust's AMPH Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Amphastar Pharmaceuticals (AMPH) stake by 9.8% in Q1 2026, selling an estimated $416 and leaving 156 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.
Parkside Financial Bank & Trust first reported a position in AMPH in Q4 2016 and has held it in 35 quarters since. The position peaked at $36.4K in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Parkside Financial Bank & Trust held 156 shares of Amphastar Pharmaceuticals worth $3.06K as of Q1 2026.
- Parkside Financial Bank & Trust sold 17 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $416.
- Amphastar Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1977 holding.
- Parkside Financial Bank & Trust first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 35 quarters since.
- Parkside Financial Bank & Trust's Amphastar Pharmaceuticals position peaked at $36.4K in Q4 2024.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.